Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.738,69
1,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Roche Holding Ag (0QQ6) Roche Holding Ag (0QQ6) Notizie

0QQ6

Roche (0QQ6)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0QQ6
DataOraFonteTitoloSimboloCompagnia
24/04/202407:00UK Regulatory[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19LSE:0QQ6Roche Holding Ag
24/04/202407:00UK Regulatory[Ad hoc-Mitteilung gemäss Art. 53 KR] Verkäufe der Roche-Gruppe steigen im ersten Quartal um 2% (CER); beide Divisionen Pharma und Diagnostics wachsen im hohen einstelligen Bereich ohne COVID-19-ProdukteLSE:0QQ6Roche Holding Ag
19/04/202407:00UK RegulatoryFDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancerLSE:0QQ6Roche Holding Ag
17/04/202408:00UK RegulatoryRoche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MSLSE:0QQ6Roche Holding Ag
15/04/202407:00UK Regulatory[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO studyLSE:0QQ6Roche Holding Ag
11/04/202407:00UK RegulatoryRoche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosisLSE:0QQ6Roche Holding Ag
26/03/202417:45UK RegulatoryRoche receives FDA approval for the first molecular test to screen for malaria in blood donorsLSE:0QQ6Roche Holding Ag
12/03/202413:30UK RegulatoryRoche Annual General Meeting 2024LSE:0QQ6Roche Holding Ag
12/03/202413:30UK RegulatoryAssemblée générale 2024 de RocheLSE:0QQ6Roche Holding Ag
12/03/202413:30UK RegulatoryRoche Generalversammlung 2024LSE:0QQ6Roche Holding Ag
05/03/202413:30UK RegulatoryRoche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of careLSE:0QQ6Roche Holding Ag
25/02/202420:00UK RegulatoryNew England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergiesLSE:0QQ6Roche Holding Ag
16/02/202417:24UK RegulatoryFDA approves Xolair as first and only medicine for children and adults with one or more food allergiesLSE:0QQ6Roche Holding Ag
01/02/202407:03UK RegulatoryNew long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)LSE:0QQ6Roche Holding Ag
01/02/202407:00UK Regulatory[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales declineLSE:0QQ6Roche Holding Ag
01/02/202407:00UK Regulatory[Ad hoc-Mitteilung gemäss Art. 53 KR] Roche übertrifft Guidance für 2023 und erzielt trotz stark rückläufigem COVID-19-Umsatz Verkaufswachstum von 1% (CER)LSE:0QQ6Roche Holding Ag
01/02/202407:00UK Regulatory[Annonce événementielle au sens de l’art. 53 RC] Roche dépasse les projections et affiche une croissance des ventes de 1 % (TCC) en 2023, malgré un net recul des ventes lié au COVID-19LSE:0QQ6Roche Holding Ag
23/10/202313:18IH Market NewsMonday’s Wall Street Highlights: Philips, Chevron, Textainer, Okta, Roivant, and moreLSE:0QQ6Roche Holding Ag
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:0QQ6

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network